Medicine
Mometasone 50 mcg nasal spray
Mometasone 50 mcg nasal spray is a generic prescription medicine for nasal use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Mometasone
- Brand
- Sold under the generic name
- Strength
- 50 mcg
- Dosage form
- Nasal spray
- Route
- Nasal
- Packs
- 1 bottle
- Manufacturers
- ApotexGolden State Medical Supply
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D07AC13 Mometasone
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 March 2016
- Identifiers
- RxCUI 1797865DailyMed set ID e30ca373-d9c0-4cad-b5c3-3be9c299dddc, 48f7ba0d-33e0-163b-2fa0-f85062768fd5NDC 60429-664, 60505-0830Application ANDA091161
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, pump in 1 carton / 120 spray, metered in 1 bottle, pump | 60505-0830-1 | Apotex | 22 March 2016 |
| 1 bottle, pump in 1 carton / 120 spray, metered in 1 bottle, pump | 60429-664-17 | Golden State Medical Supply | 29 March 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Mometasone is a corticosteroid indicated for prophylaxis of Nasal Symptoms of Seasonal Allergic Rhinitis in adult and pediatric patients 12 years of age and older, among other approved uses. It is available as nasal spray. MedsAcross supplies Mometasone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MometasoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- MOMETASONE FUROATE prescribing information (Apotex) · U.S. National Library of Medicine, DailyMed
Need Mometasone 50 mcg nasal spray for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.